Synergy Pharma (SGYP) Reports In-Line Q4 EPS

Synergy Pharma (NASDAQ: SGYP) reported Q4 EPS of ($0.12), in-line with the analyst estimate of ($0.12).

For earnings history and earnings-related data on Synergy Pharma (SGYP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• JD.com earnings preview: stronger profit expected, macro headwinds in focus
• Goldman Sachs Upgrades Tingyi Cayman Islands Holding Corp. (322:HK) (TCYMY) to Buy